People taking GLP-1 agonists for diabetes have a significantly lower risk of developing dementia compared to those using ...

For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk treated with metformin, the risk for major ...

The diabetes drug glipizide was linked to a higher risk of serious heart problems compared to dipeptidyl peptidase-4, or DPP4, inhibitors in patients with Type 2 diabetes, according to a study ...

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

In a joint clinical practice guideline, recommendations are presented for pregnancy care in individuals with preexisting diabetes mellitus.

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

A commonly used type 2 diabetes medication in the US -- Glipizide -- may be linked to a higher rate of heart-related ...

Alzheimer’s disease is a serious illness that mainly affects older people. It causes memory loss, confusion, and changes in behavior. It is the most common cause of dementia, which is a group of ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

During a live event, Mark Yarchoan, MD, and participants reviewed adverse event management for 3 different combination ...